Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19

We conducted an observational cohort study in adult patients consecutively admitted for the respiratory illness Covid-19 to our hub hospital from March 9 to April 7, 2020. The high observed rate of venous thromboembolism prompted us to increase the prophylactic doses of enoxaparin from 40 mg daily u...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinelli, Ida, Ciavarella, Alessandro, Abbattista, Maria, Aliberti, Stefano, De Zan, Valentina, Folli, Christian, Panigada, Mauro, Gori, Andrea, Artoni, Andrea, Ierardi, Anna Maria, Carrafiello, Gianpaolo, Monzani, Valter, Grasselli, Giacomo, Blasi, Francesco, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778858/
https://www.ncbi.nlm.nih.gov/pubmed/33389568
http://dx.doi.org/10.1007/s11739-020-02585-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778858/
https://www.ncbi.nlm.nih.gov/pubmed/33389568
http://dx.doi.org/10.1007/s11739-020-02585-9

Ejemplares similares